Regulations.gov document
Guidance for Industry on Drug-Induced Liver Injury: Premarketing Clinical Evaluation…
Notice · FDA-2008-D-0128 · posted Jul 30, 2009
Key facts
| Document ID | FDA-2008-D-0128-0004 |
|---|---|
| Title | Guidance for Industry on Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2008-D-0128 |
| Posted | Jul 30, 2009 |
| Federal Register citation | 74 FR 38035 |
| FR document number | E9-18135 |
| Comment period opens | Jul 30, 2009 |
| Effective date | Jul 30, 2009 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: